HGHTX
Price
$44.48
Change
+$0.20 (+0.45%)
Updated
Oct 8 closing price
Net Assets
794.95M
JNGLX
Price
$74.56
Change
+$0.48 (+0.65%)
Updated
Oct 8 closing price
Net Assets
4.49B
Interact to see
Advertisement

HGHTX vs JNGLX

Header iconHGHTX vs JNGLX Comparison
Open Charts HGHTX vs JNGLXBanner chart's image
Hartford Healthcare R5
Price$44.48
Change+$0.20 (+0.45%)
VolumeN/A
Net Assets794.95M
Janus Henderson Global Life Sciences D
Price$74.56
Change+$0.48 (+0.65%)
VolumeN/A
Net Assets4.49B
HGHTX vs JNGLX Comparison Chart in %
View a ticker or compare two or three
VS
HGHTX vs. JNGLX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHTX is a Buy and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.49B vs. HGHTX (795M). JNGLX pays higher dividends than HGHTX: JNGLX (0.33) vs HGHTX (0.17). HGHTX was incepted earlier than JNGLX: HGHTX (19 years) vs JNGLX (27 years). HGHTX (1.04) is less costly to investors than JNGLX (0.80). HGHTX is a more actively managed with annual turnover of: 40.00 vs. JNGLX (35.00). HGHTX has a lower initial minimum investment than JNGLX: HGHTX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -6.32 vs. HGHTX (-9.94). JNGLX return over 5 years is better than : 7.83 vs. HGHTX (-12.32).
HGHTXJNGLXHGHTX / JNGLX
Total Expense Ratio1.040.80130%
Annual Report Gross Expense Ratio1.040.80130%
Fund Existence19 years27 years-
Gain YTD4.2629.11847%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets795M4.49B18%
Annual Yield % from dividends0.170.3350%
Returns for 1 year-9.94-6.32157%
Returns for 3 years13.0724.1854%
Returns for 5 years-12.327.83-157%
Returns for 10 years9.1740.2423%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHCCX4.20N/A
N/A
AB Discovery Growth C
TOLCX16.66N/A
N/A
DWS RREEF Global Infrastructure C
FIDZX38.34N/A
N/A
Fidelity Advisor Intl Cap App Z
SEKRX22.88N/A
N/A
DWS Emerging Markets Equity R6
PISJX16.05N/A
N/A
Columbia Pyrford International Stock R